Overview

Comparative Cycle Control Europe

Status:
Completed

Trial end date:
2006-09-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to evaluate bleeding pattern, cycle control, and safety of this new four-phasic oral contraceptive in comparison to a reference OC.

Phase:

Phase 3

Details

Lead Sponsor:

Bayer